Consolidated Balance Sheet (Parenthetical) $ in Thousands	Dec. 31, 2022 USD ($) $ / shares shares
Investments at amortized cost	$ 809,029	[1],[2],[3],[4]
Deferred financing costs	$ 3,911
Common shares, par value | $ / shares	$ 0.001
Common shares, issued | shares	21,882,028
Common shares, outstanding | shares	21,882,028	[5]
Non-controlled, Non-affiliated Investments
Investments at amortized cost	$ 809,029

[1] As of December 31, 2022, the estimated cost basis of investments for U.S. federal tax purposes was $810,241 resulting in estimated gross unrealized gains and losses of $2,806 and $5,681, respectfully.

[2] Certain portfolio company investments are subject to contractual restrictions on sales.

[3] The amortized cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.

[4] Unless otherwise indicated, the Company’s portfolio companies are domiciled in the United States. Under the Investment Company Act of 1940, as amended (the “1940 Act”), the Company would “control” a portfolio company if the Company owned
more than 25% of its outstanding voting securities and/or had the power to exercise control over the management or policies of
such portfolio company. As of December 31, 2022, the Company does not “control” any of the portfolio companies. Also under the Investment Company Act of 1940, as amended (the “1940 Act”), the Company would be deemed to be an "Affiliated Person" of a portfolio company if the Company owns more than 5% of the portfolio company's outstanding voting securities. As of December 31, 2022, the Company does not identify any of its portfolio companies as affiliates.

[5] Table may not sum due to rounding.